{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T22:42:05Z","timestamp":1789771325413,"version":"4.0.1"},"reference-count":156,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["15-26865A"],"award-info":[{"award-number":["15-26865A"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"DOI":"10.3389\/fmed.2017.00066","type":"journal-article","created":{"date-parts":[[2017,5,30]],"date-time":"2017-05-30T04:08:37Z","timestamp":1496117317000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":41,"title":["Complement in Kidney Transplantation"],"prefix":"10.3389","volume":"4","author":[{"given":"Marek","family":"Cernoch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ondrej","family":"Viklicky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,5,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3389\/fimmu.2015.00257","article-title":"Complement system part II: role in immunity","volume":"6","author":"Merle","year":"2015","journal-title":"Front Immunol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/cr.2009.139","article-title":"Complement and its role in innate and adaptive immune responses","volume":"20","author":"Dunkelberger","year":"2010","journal-title":"Cell Res"},{"key":"B3","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3389\/fimmu.2014.00402","article-title":"Complement, c1q, and c1q-related molecules regulate macrophage polarization","volume":"5","author":"Bohlson","year":"2014","journal-title":"Front Immunol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1021\/bi500157z","article-title":"The making of a macromolecular machine: assembly of the membrane attack complex","volume":"53","author":"Bubeck","year":"2014","journal-title":"Biochemistry"},{"key":"B5","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1084\/jem.194.6.781","article-title":"C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells","volume":"194","author":"Ogden","year":"2001","journal-title":"J Exp Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"28540","DOI":"10.1074\/jbc.M704354200","article-title":"C4b-binding protein and factor H compensate for the loss of membrane-bound complement inhibitors to protect apoptotic cells against excessive complement attack","volume":"282","author":"Trouw","year":"2007","journal-title":"J Biol Chem"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1016\/j.molimm.2009.04.027","article-title":"The role of the anaphylatoxins in health and disease","volume":"46","author":"Klos","year":"2009","journal-title":"Mol Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3389\/fimmu.2015.00262","article-title":"Complement system part I \u2013 molecular mechanisms of activation and regulation","volume":"6","author":"Merle","year":"2015","journal-title":"Front Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"3357","DOI":"10.1073\/pnas.93.8.3357","article-title":"Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2","volume":"93","author":"Molina","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B10","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.immuni.2008.02.001","article-title":"Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4+ T cells","volume":"28","author":"Strainic","year":"2008","journal-title":"Immunity"},{"key":"B11","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/ni.2499","article-title":"Absence of signaling into CD4? cells via C3aR and C5aR enables autoinductive TGF-\u03b21 signaling and induction of Foxp3? regulatory T cells","volume":"14","author":"Strainic","year":"2013","journal-title":"Nat Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s00441-010-1034-0","article-title":"The complement system","volume":"343","author":"Sarma","year":"2011","journal-title":"Cell Tissue Res"},{"key":"B13","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.imlet.2004.06.015","article-title":"Structural and functional anatomy of the globular domain of complement protein C1q","volume":"95","author":"Kishore","year":"2004","journal-title":"Immunol Lett"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.1002\/eji.200323888","article-title":"Mannose-binding lectin engagement with late apoptotic and necrotic cells","volume":"33","author":"Nauta","year":"2003","journal-title":"Eur J Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"13916","DOI":"10.1073\/pnas.1311113110","article-title":"Structural basis of the C1q\/C1s interaction and its central role in assembly of the C1 complex of complement activation","volume":"110","author":"Girija","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B16","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1084\/jem.154.3.856","article-title":"Formation of the initial C3 convertase of the alternative complement pathway. Acquisition of C3b-like activities by spontaneous hydrolysis of the putative thioester in native C3","volume":"154","author":"Pangburn","year":"1981","journal-title":"J Exp Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1042\/BJ20100759","article-title":"Self-association and domain rearrangements between complement C3 and C3u provide insight into the activation mechanism of C3","volume":"431","author":"Li","year":"2010","journal-title":"Biochem J"},{"key":"B18","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1084\/jem.142.4.856","article-title":"Properdin: binding to C3b and stabilization of the C3b-dependent C3 convertase","volume":"142","author":"Fearon","year":"1975","journal-title":"J Exp Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1146\/annurev-immunol-030409-101250","article-title":"Properdin: emerging roles of a pattern-recognition molecule","volume":"28","author":"Kemper","year":"2010","journal-title":"Annu Rev Immunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.molimm.2013.06.002","article-title":"Properdin in complement activation and tissue injury","volume":"56","author":"Lesher","year":"2013","journal-title":"Mol Immunol"},{"key":"B21","doi-asserted-by":"crossref","first-page":"8641","DOI":"10.1016\/S0021-9258(17)39778-8","article-title":"Molecular composition of the tubular structure of the membrane attack complex of complement","volume":"259","author":"Podack","year":"1984","journal-title":"J Biol Chem"},{"key":"B22","doi-asserted-by":"publisher","first-page":"10587","DOI":"10.1038\/ncomms10587","article-title":"Structural basis of complement membrane attack complex formation","volume":"7","author":"Serna","year":"2016","journal-title":"Nat Commun"},{"key":"B23","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/0161-5890(92)90106-8","article-title":"Activation of the fifth component of human complement, C5, without cleavage, by methionine oxidizing agents","volume":"29","author":"Vogt","year":"1992","journal-title":"Mol Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1160\/TH09-02-0103","article-title":"Local complement activation triggers neutrophil recruitment to the site of thrombus formation in acute myocardial infarction","volume":"102","author":"Distelmaier","year":"2009","journal-title":"Thromb Haemost"},{"key":"B25","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1177\/1479164111432788","article-title":"Complement C3 is a novel plasma clot component with anti-fibrinolytic properties","volume":"9","author":"Howes","year":"2012","journal-title":"Diab Vasc Dis Res"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1016\/S0002-9440(10)64461-6","article-title":"Generation of C5a by phagocytic cells","volume":"161","author":"Huber-Lang","year":"2002","journal-title":"Am J Pathol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"R269","DOI":"10.1186\/ar4117","article-title":"Autoantibody-mediated arthritis in the absence of C3 and activating Fc\u03b3 receptors: C5 is activated by the coagulation cascade","volume":"14","author":"Auger","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"B28","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.ebiom.2016.02.011","article-title":"Complement activation in arterial and venous thrombosis is mediated by plasmin","volume":"5","author":"Foley","year":"2016","journal-title":"EBioMedicine"},{"key":"B29","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/0014-5793(94)00463-3","article-title":"Activation of human neutrophils by C3a and C5A. Comparison of the effects on shape changes, chemotaxis, secretion, and respiratory burst","volume":"346","author":"Ehrengruber","year":"1994","journal-title":"FEBS Lett"},{"key":"B30","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1182\/blood.V89.8.2863","article-title":"C3a and C5a stimulate chemotaxis of human mast cells","volume":"89","author":"Hartmann","year":"1997","journal-title":"Blood"},{"key":"B31","doi-asserted-by":"crossref","first-page":"4018","DOI":"10.4049\/jimmunol.162.7.4018","article-title":"Human T cells express the C5a receptor and are chemoattracted to C5a","volume":"162","author":"Nataf","year":"1999","journal-title":"J Immunol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/eji.1830240304","article-title":"C3a activates reactive oxygen radical species production and intracellular calcium transients in human eosinophils","volume":"24","author":"Elsner","year":"1994","journal-title":"Eur J Immunol"},{"key":"B33","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1182\/blood.V83.11.3324.3324","article-title":"C3a activates the respiratory burst in human polymorphonuclear neutrophilic leukocytes via pertussis toxin-sensitive G-proteins","volume":"83","author":"Elsner","year":"1994","journal-title":"Blood"},{"key":"B34","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1111\/1523-1747.ep12378589","article-title":"Complement peptides C3a- and C5a-induced mediator release from dissociated human skin mast cells","volume":"102","author":"el-Lati","year":"1994","journal-title":"J Invest Dermatol"},{"key":"B35","doi-asserted-by":"crossref","first-page":"453","DOI":"10.4049\/jimmunol.162.1.453","article-title":"Regulation of IL-6 synthesis in human peripheral blood mononuclear cells by C3a and C3a(desArg)","volume":"162","author":"Fischer","year":"1999","journal-title":"J Immunol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1084\/jem.20030374","article-title":"The proinflammatory mediators C3a and C5a are essential for liver regeneration","volume":"198","author":"Strey","year":"2003","journal-title":"J Exp Med"},{"key":"B37","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1111\/jcmm.12667","article-title":"Complement inhibition decreases early fibrogenic events in the lung of septic baboons","volume":"19","author":"Silasi-Mansat","year":"2015","journal-title":"J Cell Mol Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","article-title":"The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta","volume":"10","author":"Martinon","year":"2002","journal-title":"Mol Cell"},{"key":"B39","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.cell.2010.01.040","article-title":"The inflammasomes","volume":"140","author":"Schroder","year":"2010","journal-title":"Cell"},{"key":"B40","doi-asserted-by":"publisher","first-page":"3473","DOI":"10.1182\/blood-2013-05-502229","article-title":"C3a modulates IL-1\u03b2 secretion in human monocytes by regulating ATP efflux and subsequent NLRP3 inflammasome activation","volume":"122","author":"Asgari","year":"2013","journal-title":"Blood"},{"key":"B41","doi-asserted-by":"publisher","first-page":"3669","DOI":"10.1002\/eji.201444560","article-title":"Complement C5a potentiates uric acid crystal-induced IL-1\u03b2 production","volume":"44","author":"An","year":"2014","journal-title":"Eur J Immunol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.4049\/jimmunol.1302484","article-title":"Cholesterol crystals induce complement-dependent inflammasome activation and cytokine release","volume":"192","author":"Samstad","year":"2014","journal-title":"J Immunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1242\/jcs.179291","article-title":"Complement-mediated \u2019bystander\u2019 damage initiates host NLRP3 inflammasome activation","volume":"129","author":"Suresh","year":"2016","journal-title":"J Cell Sci"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1084\/jem.166.5.1221","article-title":"The mechanism of action of decay-accelerating factor (DAF). DAF inhibits the assembly of C3 convertases by dissociating C2a and Bb","volume":"166","author":"Fujita","year":"1987","journal-title":"J Exp Med"},{"key":"B45","doi-asserted-by":"publisher","first-page":"31160","DOI":"10.1074\/jbc.274.44.31160","article-title":"Decay accelerating activity of complement receptor type 1 (CD35). Two active sites are required for dissociating C5 convertases","volume":"274","author":"Krych-Goldberg","year":"1999","journal-title":"J Biol Chem"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1074\/jbc.M109322200","article-title":"Decay-accelerating factor (DAF), complement receptor 1 (CR1), and factor H dissociate the complement AP C3 convertase (C3bBb) via sites on the type A domain of Bb","volume":"277","author":"Hourcade","year":"2002","journal-title":"J Biol Chem"},{"key":"B47","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.molimm.2015.07.016","article-title":"Role of complement receptor 1 (CR1; CD35) on epithelial cells: a model for understanding complement-mediated damage in the kidney","volume":"67","author":"Java","year":"2015","journal-title":"Mol Immunol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1042\/bst0300978","article-title":"Structural and functional studies of complement inhibitor C4b-binding protein","volume":"30","author":"Blom","year":"2002","journal-title":"Biochem Soc Trans"},{"key":"B49","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.imbio.2011.10.003","article-title":"Complement factor H-ligand interactions: self-association, multivalency and dissociation constants","volume":"217","author":"Perkins","year":"2012","journal-title":"Immunobiology"},{"key":"B50","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1084\/jem.163.4.837","article-title":"Purification and characterization of a membrane protein (gp45-70) that is a cofactor for cleavage of C3b and C4b","volume":"163","author":"Seya","year":"1986","journal-title":"J Exp Med"},{"key":"B51","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1111\/j.1600-6143.2011.03754.x","article-title":"Delayed graft function in the kidney transplant","volume":"11","author":"Siedlecki","year":"2011","journal-title":"Am J Transplant"},{"key":"B52","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1097\/00024382-200405000-00002","article-title":"The role of the complement system in ischemia-reperfusion injury","volume":"21","author":"Arumugam","year":"2004","journal-title":"Shock"},{"key":"B53","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/BF02815613","article-title":"Renal ischemia\u2013reperfusion injury: an inescapable event affecting kidney transplantation outcome","volume":"46","author":"Bohmova","year":"2001","journal-title":"Folia Microbiol (Praha)"},{"key":"B54","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1097\/TP.0b013e3182a95d04","article-title":"Tubular atrophy and low netrin-1 gene expression are associated with delayed kidney allograft function","volume":"97","author":"Wohlfahrtova","year":"2014","journal-title":"Transplantation"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1111\/j.1600-6143.2005.00873.x","article-title":"Local complement C3 expression is upregulated in humoral and cellular rejection of renal allografts","volume":"5","author":"Serins\u00f6z","year":"2005","journal-title":"Am J Transplant"},{"key":"B56","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1681\/ASN.2005070698","article-title":"Treatment with an inhibitory monoclonal antibody to mouse factor B protects mice from induction of apoptosis and renal ischemia\/reperfusion injury","volume":"17","author":"Thurman","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1096\/fj.05-4747com","article-title":"Local extravascular pool of C3 is a determinant of postischemic acute renal failure","volume":"20","author":"Farrar","year":"2006","journal-title":"FASEB J"},{"key":"B58","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1097\/01.TP.0000044455.05584.2A","article-title":"Inhibition of complement factor C5 protects against renal ischemia-reperfusion injury: inhibition of late apoptosis and inflammation","volume":"75","author":"De Vries","year":"2003","journal-title":"Transplantation"},{"key":"B59","doi-asserted-by":"publisher","first-page":"3883","DOI":"10.4049\/jimmunol.170.7.3883","article-title":"Complement factor C5a mediates renal ischemia-reperfusion injury independent from neutrophils","volume":"170","author":"de Vries","year":"2003","journal-title":"J Immunol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/j.1365-2249.2008.03678.x","article-title":"Pharmacological targeting of C5a receptors during organ preservation improves kidney graft survival","volume":"153","author":"Lewis","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1681\/ASN.2011111072","article-title":"C3a and C5a promote renal ischemia-reperfusion injury","volume":"23","author":"Peng","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"5793","DOI":"10.4049\/jimmunol.179.9.5793","article-title":"Decay accelerating factor can control T cell differentiation into IFN-gamma-producing effector cells via regulating local C5a-induced IL-12 production","volume":"179","author":"Lalli","year":"2007","journal-title":"J Immunol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1111\/ajt.12130","article-title":"Complement mediated renal inflammation induced by donor brain death: role of renal C5a-C5aR interaction","volume":"13","author":"van Werkhoven","year":"2013","journal-title":"Am J Transplant"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1681\/ASN.2008111145","article-title":"Expression of complement components differs between kidney allografts from living and deceased donors","volume":"20","author":"Naesens","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1097\/00007890-200002150-00017","article-title":"Activation of inflammatory mediators in rat renal isografts by donor brain death","volume":"69","author":"Kusaka","year":"2000","journal-title":"Transplantation"},{"key":"B66","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1093\/ndt\/gfq717","article-title":"Local renal complement C3 induction by donor brain death is associated with reduced renal allograft function after transplantation","volume":"26","author":"Damman","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1161\/CIRCULATIONAHA.112.000784","article-title":"Donor brain death exacerbates complement-dependent ischemia\/reperfusion injury in transplanted hearts","volume":"127","author":"Atkinson","year":"2013","journal-title":"Circulation"},{"key":"B68","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/TP.0b013e318222c9a0","article-title":"Systemic complement activation in deceased donors is associated with acute rejection after renal transplantation in the recipient","volume":"92","author":"Damman","year":"2011","journal-title":"Transplantation"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1681\/ASN.2012060560","article-title":"Renal ischemia-reperfusion injury amplifies the humoral immune response","volume":"24","author":"Fuquay","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1111\/j.1600-6143.2011.03561.x","article-title":"Anti-complement component C5 mAb synergizes with CTLA4Ig to inhibit alloreactive T cells and prolong cardiac allograft survival in mice","volume":"11","author":"Raedler","year":"2011","journal-title":"Am J Transplant"},{"key":"B71","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1152\/jappl.1999.86.3.938","article-title":"Intestinal reperfusion injury is mediated by IgM and complement","volume":"86","author":"Williams","year":"1999","journal-title":"J Appl Physiol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"3886","DOI":"10.1073\/pnas.0400347101","article-title":"Identification of a specific self-reactive IgM antibody that initiates intestinal ischemia\/reperfusion injury","volume":"101","author":"Zhang","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B73","doi-asserted-by":"publisher","first-page":"4727","DOI":"10.4049\/jimmunol.177.7.4727","article-title":"Activation of the lectin pathway by natural IgM in a model of ischemia\/reperfusion injury","volume":"177","author":"Zhang","year":"2006","journal-title":"J Immunol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"H1853","DOI":"10.1152\/ajpheart.00049.2009","article-title":"Myocardial ischemia and reperfusion injury is dependent on both IgM and mannose-binding lectin","volume":"297","author":"Busche","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1097\/SLA.0b013e3181a38f45","article-title":"Complement-mediated ischemia-reperfusion injury: lessons learned from animal and clinical studies","volume":"249","author":"Diepenhorst","year":"2009","journal-title":"Ann Surg"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1172\/JCI8621","article-title":"Predominant role for C5b-9 in renal ischemia\/reperfusion injury","volume":"105","author":"Zhou","year":"2000","journal-title":"J Clin Invest"},{"key":"B77","doi-asserted-by":"publisher","first-page":"6373","DOI":"10.4049\/jimmunol.174.10.6373","article-title":"Gastrointestinal ischemia-reperfusion injury is lectin complement pathway dependent without involving C1q","volume":"174","author":"Hart","year":"2005","journal-title":"J Immunol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1016\/j.molimm.2009.11.022","article-title":"Early complement factors in the local tissue immunocomplex generated during intestinal ischemia\/reperfusion injury","volume":"47","author":"Lee","year":"2010","journal-title":"Mol Immunol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/S0002-9440(10)63839-4","article-title":"Role for the alternative complement pathway in ischemia\/reperfusion injury","volume":"162","author":"Stahl","year":"2003","journal-title":"Am J Pathol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"3552","DOI":"10.4049\/jimmunol.1202275","article-title":"Blocking properdin, the alternative pathway, and anaphylatoxin receptors ameliorates renal ischemia-reperfusion injury in decay-accelerating factor and CD59 double-knockout mice","volume":"190","author":"Miwa","year":"2013","journal-title":"J Immunol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1016\/S0002-9440(10)65026-2","article-title":"Complement activation after oxidative stress: role of the lectin complement pathway","volume":"156","author":"Collard","year":"2000","journal-title":"Am J Pathol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/S0002-9440(10)61779-8","article-title":"Endothelial oxidative stress activates the lectin complement pathway: role of cytokeratin 1","volume":"159","author":"Collard","year":"2001","journal-title":"Am J Pathol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/S0002-9440(10)63424-4","article-title":"The mannose-binding lectin-pathway is involved in complement activation in the course of renal ischemia-reperfusion injury","volume":"165","author":"de Vries","year":"2004","journal-title":"Am J Pathol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1111\/j.1365-3083.2005.01591.x","article-title":"Mannan-binding lectin recognizes structures on ischaemic reperfused mouse kidneys and is implicated in tissue injury","volume":"61","author":"M\u00f8ller-Kristensen","year":"2005","journal-title":"Scand J Immunol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"3996","DOI":"10.1096\/fj.13-246306","article-title":"Mannan-binding lectin-associated serine protease 2 is critical for the development of renal ischemia reperfusion injury and mediates tissue injury in the absence of complement C4","volume":"28","author":"Asgari","year":"2014","journal-title":"FASEB J"},{"key":"B86","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1111\/ajt.13797","article-title":"Targeting complement pathways during cold ischemia and reperfusion prevents delayed graft function","volume":"16","author":"Yu","year":"2016","journal-title":"Am J Transplant"},{"key":"B87","unstructured":"Alexion Announces Top-Line Results from Phase 2\/3 PROTECT Study of Eculizumab (Soliris2017"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1111\/j.1600-6143.2010.03156.x","article-title":"Thrombotic microangiopathy after kidney transplantation","volume":"10","author":"Noris","year":"2010","journal-title":"Am J Transplant"},{"key":"B89","first-page":"235","article-title":"Review of thrombotic microangiopathy (TMA), and post-renal transplant TMA","volume":"17","author":"Ardalan","year":"2006","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"B90","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1097\/MNH.0b013e3283378f25","article-title":"Thrombotic microangiopathy: new insights","volume":"19","author":"Benz","year":"2010","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"B91","doi-asserted-by":"publisher","first-page":"335","DOI":"10.5414\/CNP67335","article-title":"De novo thrombotic microangiopathy. An underrated complication of renal transplantation","volume":"67","author":"Ponticelli","year":"2007","journal-title":"Clin Nephrol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2014-207630","article-title":"A \u2019silent\u2019, new polymorphism of factor H and apparent de novo atypical haemolytic uraemic syndrome after kidney transplantation","author":"Broeders","year":"2014","journal-title":"BMJ Case Rep"},{"key":"B93","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","article-title":"Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome","volume":"368","author":"Legendre","year":"2013","journal-title":"N Engl J Med"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1038\/ki.2014.423","article-title":"Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies","volume":"87","author":"Licht","year":"2015","journal-title":"Kidney Int"},{"key":"B95","doi-asserted-by":"publisher","first-page":"3337","DOI":"10.1111\/j.1600-6143.2012.04252.x","article-title":"Eculizumab for atypical hemolytic uremic syndrome recurrence in renal transplantation","volume":"12","author":"Zuber","year":"2012","journal-title":"Am J Transplant"},{"key":"B96","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1172\/JCI113780","article-title":"Local extrahepatic expression of complement genes C3, factor B, C2, and C4 is increased in murine lupus nephritis","volume":"82","author":"Passwell","year":"1988","journal-title":"J Clin Invest"},{"key":"B97","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/nm0602-582","article-title":"Local synthesis of complement component C3 regulates acute renal transplant rejection","volume":"8","author":"Pratt","year":"2002","journal-title":"Nat Med"},{"key":"B98","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1111\/ajt.12405","article-title":"Immune cell-derived C3a and C5a costimulate human T cell alloimmunity","volume":"13","author":"Cravedi","year":"2013","journal-title":"Am J Transplant"},{"key":"B99","doi-asserted-by":"publisher","first-page":"5921","DOI":"10.4049\/jimmunol.1300847","article-title":"Cutting edge: receptors for C3a and C5a modulate stability of alloantigen-reactive induced regulatory T cells","volume":"190","author":"van der Touw","year":"2013","journal-title":"J Immunol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1681\/ASN.2007111267","article-title":"Complement 5a receptor inhibition improves renal allograft survival","volume":"19","author":"Gueler","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"5084","DOI":"10.1182\/blood-2008-05-156646","article-title":"Cyclic AMP plays a critical role in C3a-receptor-mediated regulation of dendritic cells in antigen uptake and T-cell stimulation","volume":"112","author":"Li","year":"2008","journal-title":"Blood"},{"key":"B102","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1084\/jem.20121525","article-title":"Signaling through C5a receptor and C3a receptor diminishes function of murine natural regulatory T cells","volume":"210","author":"Kwan","year":"2013","journal-title":"J Exp Med"},{"key":"B103","doi-asserted-by":"publisher","first-page":"33489","DOI":"10.1038\/srep33489","article-title":"Complement component 3 deficiency prolongs MHC-II disparate skin allograft survival by increasing the CD4(+) CD25(+) regulatory T cells population","volume":"6","author":"Zheng","year":"2016","journal-title":"Sci Rep"},{"key":"B104","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13578-015-0052-8","article-title":"Complement C4 induces regulatory T cells differentiation through dendritic cell in systemic lupus erythematosus","volume":"5","author":"Cheng","year":"2015","journal-title":"Cell Biosci"},{"key":"B105","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1189\/jlb.3A0614-278R","article-title":"Complement protein C1q bound to apoptotic cells suppresses human macrophage and dendritic cell-mediated Th17 and Th1 T cell subset proliferation","volume":"97","author":"Clarke","year":"2015","journal-title":"J Leukoc Biol"},{"key":"B106","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1084\/jem.20040863","article-title":"The complement inhibitory protein DAF (CD55) suppresses T cell immunity in vivo","volume":"201","author":"Liu","year":"2005","journal-title":"J Exp Med"},{"key":"B107","doi-asserted-by":"publisher","first-page":"4580","DOI":"10.4049\/jimmunol.181.7.4580","article-title":"Donor deficiency of decay-accelerating factor accelerates murine T cell-mediated cardiac allograft rejection","volume":"181","author":"Pavlov","year":"2008","journal-title":"J Immunol"},{"key":"B108","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1172\/JCI61019","article-title":"Antigen-presenting cell-derived complement modulates graft-versus-host disease","volume":"122","author":"Kwan","year":"2012","journal-title":"J Clin Invest"},{"key":"B109","doi-asserted-by":"publisher","first-page":"e0148881","DOI":"10.1371\/journal.pone.0148881","article-title":"Depression of complement regulatory factors in rat and human renal grafts is associated with the progress of acute T-cell mediated rejection","volume":"11","author":"Yamanaka","year":"2016","journal-title":"PLoS One"},{"key":"B110","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/ni.1917","article-title":"Complement regulator CD46 temporally regulates cytokine production by conventional and unconventional T cells","volume":"11","author":"Cardone","year":"2010","journal-title":"Nat Immunol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1111\/tri.12440","article-title":"Living-donor kidney transplantation for atypical haemolytic uremic syndrome with pre-emptive eculizumab use","volume":"28","author":"Parikova","year":"2015","journal-title":"Transpl Int"},{"key":"B112","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/MOT.0000000000000037","article-title":"Mechanisms of rejection: role of complement","volume":"19","author":"Farrar","year":"2014","journal-title":"Curr Opin Organ Transplant"},{"key":"B113","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1111\/j.1600-6143.2005.00841.x","article-title":"Association between mannose-binding lectin levels and graft survival in kidney transplantation","volume":"5","author":"Berger","year":"2005","journal-title":"Am J Transplant"},{"key":"B114","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1093\/ndt\/gfl210","article-title":"Immunohistochemical evidence of activated lectin pathway in kidney allografts with peritubular capillary C4d deposition","volume":"21","author":"Imai","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"B115","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/ki.1989.302","article-title":"Classical pathway of complement activation in normal and diseased human glomeruli","volume":"36","author":"Zwirner","year":"1989","journal-title":"Kidney Int"},{"key":"B116","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1038\/ki.1993.187","article-title":"Capillary deposition of C4d complement fragment and early renal graft loss","volume":"43","author":"Feucht","year":"1993","journal-title":"Kidney Int"},{"key":"B117","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1046\/j.1523-1755.2001.00495.x","article-title":"Impact of humoral alloreactivity early after transplantation on the long-term survival of renal allografts","volume":"59","author":"Lederer","year":"2001","journal-title":"Kidney Int"},{"key":"B118","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1681\/ASN.V131234","article-title":"C4d deposition in acute rejection: an independent long-term prognostic factor","volume":"13","author":"Herzenberg","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"B119","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1111\/j.1600-6143.2008.02159.x","article-title":"Banff 07 classification of renal allograft pathology: updates and future directions","volume":"8","author":"Solez","year":"2008","journal-title":"Am J Transplant"},{"key":"B120","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1097\/MOT.0000000000000072","article-title":"An updated Banff schema for diagnosis of antibody-mediated rejection in renal allografts","volume":"19","author":"Hass","year":"2014","journal-title":"Curr Opin Organ Transplant"},{"key":"B121","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.1399-0012.2007.00710.x","article-title":"Donor-specific antibody in chronic rejection is associated with glomerulopathy, thickening of peritubular capillary basement membrane, but not C4d deposition","volume":"21","author":"Miura","year":"2007","journal-title":"Clin Transplant"},{"key":"B122","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1111\/j.1600-6143.2009.02761.x","article-title":"Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining","volume":"9","author":"Sis","year":"2009","journal-title":"Am J Transplant"},{"key":"B123","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1097\/MOT.0000000000000216","article-title":"Effects of complement activation on allograft injury","volume":"20","author":"Sheen","year":"2015","journal-title":"Curr Opin Organ Transplant"},{"key":"B124","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.4049\/jimmunol.160.11.5273","article-title":"Expression of complement receptors 1 and 2 on follicular dendritic cells is necessary for the generation of a strong antigen-specific IgG response","volume":"160","author":"Fang","year":"1998","journal-title":"J Immunol"},{"key":"B125","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1126\/science.271.5247.348","article-title":"C3d of complement as a molecular adjuvant: bridging innate and acquired immunity","volume":"271","author":"Dempsey","year":"1996","journal-title":"Science"},{"key":"B126","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1016\/j.humimm.2012.07.330","article-title":"Role of complement and NK cells in antibody mediated rejection","volume":"73","author":"Akiyoshi","year":"2012","journal-title":"Hum Immunol"},{"key":"B127","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1161\/CIRCULATIONAHA.113.002972","article-title":"Alloantibody and complement promote T cell-mediated cardiac allograft vasculopathy through non-canonical nuclear factor-\u03baB signaling in endothelial cells","volume":"128","author":"Jane-Wit","year":"2013","journal-title":"Circulation"},{"key":"B128","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1097\/TP.0b013e318203fd26","article-title":"C1q-fixing human leukocyte antigen antibodies are specific for predicting transplant glomerulopathy and late graft failure after kidney transplantation","volume":"91","author":"Yabu","year":"2011","journal-title":"Transplantation"},{"key":"B129","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1056\/NEJMoa1302506","article-title":"Complement-binding anti-HLA antibodies and kidney-allograft survival","volume":"369","author":"Loupy","year":"2013","journal-title":"N Engl J Med"},{"key":"B130","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.trim.2013.07.002","article-title":"Clinical relevance of pretransplant anti-HLA donor-specific antibodies: does C1q-fixation matter?","volume":"29","author":"Crespo","year":"2013","journal-title":"Transpl Immunol"},{"key":"B131","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1111\/j.1600-6143.2012.04053.x","article-title":"Expansion of polyreactive B cells cross-reactive to HLA and self in the blood of a patient with kidney graft rejection","volume":"12","author":"Porcheray","year":"2012","journal-title":"Am J Transplant"},{"key":"B132","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1097\/TP.0b013e3181d72091","article-title":"Chronic humoral rejection of human kidney allografts associates with broad autoantibody responses","volume":"89","author":"Porcheray","year":"2010","journal-title":"Transplantation"},{"key":"B133","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1111\/ajt.12394","article-title":"Polyreactive antibodies developing amidst humoral rejection of human kidney grafts bind apoptotic cells and activate complement","volume":"13","author":"Porcheray","year":"2013","journal-title":"Am J Transplant"},{"key":"B134","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1111\/j.1600-6143.2011.03757.x","article-title":"Terminal complement inhibition decreases antibody-mediated rejection in sensitized renal transplant recipients","volume":"11","author":"Stegall","year":"2011","journal-title":"Am J Transplant"},{"key":"B135","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/nrneph.2012.212","article-title":"The role of complement in antibody-mediated rejection in kidney transplantation","volume":"8","author":"Stegall","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"B136","unstructured":"Alexion Provides Update on Phase 2 Clinical Trial with Eculizumab in Antibody Mediated Rejection (AMR) in Living-Donor Kidney Transplant Recipients2017"},{"key":"B137","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/j.1600-6143.2011.03836.x","article-title":"A novel pathway of chronic allograft rejection mediated by NK cells and alloantibody","volume":"12","author":"Hirohashi","year":"2012","journal-title":"Am J Transplant"},{"key":"B138","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1111\/j.1600-6143.2010.03201.x","article-title":"NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: evidence for NK cell involvement in antibody-mediated rejection","volume":"10","author":"Hidalgo","year":"2010","journal-title":"Am J Transplant"},{"key":"B139","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1111\/j.1600-6143.2011.03970.x","article-title":"Interpreting NK cell transcripts versus T cell transcripts in renal transplant biopsies","volume":"12","author":"Hidalgo","year":"2012","journal-title":"Am J Transplant"},{"key":"B140","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.kint.2016.02.030","article-title":"Natural killer cells play a critical role in mediating inflammation and graft failure during antibody-mediated rejection of kidney allografts","volume":"89","author":"Kohei","year":"2016","journal-title":"Kidney Int"},{"key":"B141","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3389\/fimmu.2016.00288","article-title":"Antibody-dependent NK cell activation is associated with late kidney allograft dysfunction and the complement-independent alloreactive potential of donor-specific antibodies","volume":"7","author":"Legris","year":"2016","journal-title":"Front Immunol"},{"key":"B142","doi-asserted-by":"publisher","first-page":"4057","DOI":"10.1016\/j.molimm.2008.06.028","article-title":"Biological activities of C1 inhibitor","volume":"45","author":"Davis","year":"2008","journal-title":"Mol Immunol"},{"key":"B143","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.molimm.2013.01.009","article-title":"The control of the complement lectin pathway activation revisited: both C1-inhibitor and antithrombin are likely physiological inhibitors, while \u03b12-macroglobulin is not","volume":"54","author":"Par\u00e9j","year":"2013","journal-title":"Mol Immunol"},{"key":"B144","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/ki.2010.75","article-title":"Recombinant human C1-inhibitor prevents acute antibody-mediated rejection in alloimmunized baboons","volume":"78","author":"Tillou","year":"2010","journal-title":"Kidney Int"},{"key":"B145","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/TP.0000000000000592","article-title":"A phase I\/II placebo-controlled trial of C1-inhibitor for prevention of antibody-mediated rejection in HLA sensitized patients","volume":"99","author":"Vo","year":"2015","journal-title":"Transplantation"},{"key":"B146","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.molimm.2012.07.012","article-title":"A novel peptide inhibitor of classical and lectin complement activation including ABO incompatibility","volume":"53","author":"Mauriello","year":"2013","journal-title":"Mol Immunol"},{"key":"B147","doi-asserted-by":"publisher","first-page":"e0132446","DOI":"10.1371\/journal.pone.0132446","article-title":"Peptide inhibitor of complement C1 (PIC1) rapidly inhibits complement activation after intravascular injection in rats","volume":"10","author":"Sharp","year":"2015","journal-title":"PLoS One"},{"key":"B148","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1038\/nbt1207-1488c","article-title":"Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria","volume":"25","author":"Rother","year":"2007","journal-title":"Nat Biotechnol"},{"key":"B149","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1056\/NEJMoa061648","article-title":"The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria","volume":"355","author":"Hillmen","year":"2006","journal-title":"N Engl J Med"},{"key":"B150","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1053\/j.ajkd.2015.12.034","article-title":"Terminal complement inhibitor eculizumab in adult patients with atypical hemolytic uremic syndrome: a single-arm, open-label trial","volume":"68","author":"Fakhouri","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"B151","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.1016\/j.transproceed.2012.03.053","article-title":"Case report: eculizumab rescue of severe accelerated antibody-mediated rejection after ABO-incompatible kidney transplant","volume":"44","author":"Stewart","year":"2012","journal-title":"Transplant Proc"},{"key":"B152","doi-asserted-by":"publisher","first-page":"e551","DOI":"10.1542\/peds.2014-2275","article-title":"Eculizumab to treat antibody-mediated rejection in a 7-year-old kidney transplant recipient","volume":"135","author":"Chehade","year":"2015","journal-title":"Pediatrics"},{"key":"B153","doi-asserted-by":"publisher","first-page":"9874261","DOI":"10.1155\/2016\/9874261","article-title":"Eculizumab for the treatment of severe antibody-mediated rejection: a case report and review of the literature","volume":"2016","author":"Tran","year":"2016","journal-title":"Case Rep Transplant"},{"key":"B154","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1111\/ajt.13168","article-title":"Positive crossmatch kidney transplant recipients treated with eculizumab: outcomes beyond 1 year","volume":"15","author":"Cornell","year":"2015","journal-title":"Am J Transplant"},{"key":"B155","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1097\/TP.0000000000000184","article-title":"Report of the inefficacy of eculizumab in two cases of severe antibody-mediated rejection of renal grafts","volume":"98","author":"Burbach","year":"2014","journal-title":"Transplantation"},{"key":"B156","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1111\/tri.12396","article-title":"Antibody-mediated rejection despite inhibition of terminal complement","volume":"27","author":"Bentall","year":"2014","journal-title":"Transpl Int"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmed.2017.00066\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T20:04:41Z","timestamp":1692821081000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmed.2017.00066\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,30]]},"references-count":156,"alternative-id":["10.3389\/fmed.2017.00066"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2017.00066","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,30]]},"article-number":"66"}}